Lamivudine Tablet — FDA Drug Shortage

To Be Discontinued — ViiV Healthcare Company

The FDA lists a drug shortage record for Lamivudine Tablet (tablet) from ViiV Healthcare Company with status To Be Discontinued. The shortage was first posted on Oct 19, 2026.

Shortage details

Status
To Be Discontinued
Company
ViiV Healthcare Company
Package NDC
49702-204-13
Dosage Form
Tablet
Presentation
Epivir, Tablet, 300 mg (NDC 49702-204-13)
Initial Posting
Oct 19, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.